949 A SINGLE- AND MULTIPLE-DOSE ASSESSMENT OF THE SAFETY AND PHARMACOKINETICS OF SCH 900518 AND ITS EFFECT ON THE PHARMACOKINETICS OF MIDAZOLAM IN HEALTHY SUBJECTS
Hughes, E, Treitel, M, Gupta, S, Xu, C, Hu, C, Yue, B, Sheth, A, Corpus, M, Marchisin, D, Prasad, P, O'Mara, E, van Vliet, A, van Lier, J
Published in Journal of hepatology (2009)
Published in Journal of hepatology (2009)
Get full text
Journal Article
948 A REGIONAL GASTROINTESTINAL ABSORPTION STUDY OF THE HCV NS3 PROTEASE INHIBITOR SCH 900518 IN HEALTHY VOLUNTEERS
Hughes, E, Wan, Y, Treitel, M, Gupta, S, Hu, C, Yue, B, Sheth, A, Corpus, M, Marchisin, D, Prasad, P, O'Mara, E, de Bres, J, Connor, A, Palaniappan, K
Published in Journal of hepatology (2009)
Published in Journal of hepatology (2009)
Get full text
Journal Article
Lack of ECG effects of BMS-986165, an oral, selective tyrosine kinase 2 (TYK2) inhibitor: results from a thorough QT study in healthy subjects
Girgis, IG, Chimalakonda, A, Jones III, JP, Dockens, R, Marchisin, D, Darbenzio, R, Singhal, S, Throup, J, Banerjee, S
Published in Skin (Milwood, N.Y.) (09.11.2019)
Published in Skin (Milwood, N.Y.) (09.11.2019)
Get full text
Journal Article